News + Blog

Find out what’s happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

Filter By:
Sort By:
  • Fitzsimons Innovation Community Releases 2025 Annual Innovation Report: Innovation in Motion
    • Blog

    Fitzsimons Innovation Community Releases 2025 Annual Innovation Report: Innovation in Motion

    Innovation does not stand still at Fitzsimons Innovation Community – and in 2025, the momentum was unmistakable. We are proud to announce the release of our 2025 Annual Innovation Report, a comprehensive look at the discoveries, partnerships, investments and infrastructure advancements shaping one of the nation’s most dynamic health innovation districts.
    • Blog

    American Heart Month: Advancing Cardiovascular Innovation Through Collaboration

    February is American Heart Month, a time to spotlight cardiovascular health and reaffirm a shared commitment to preventing and treating heart disease – the leading cause of death in the United States. It is also an opportunity to recognize how innovation, research and collaboration are reshaping the future of heart health.
  • Kelly Jean Brough
    • News

    Kelly Brough Shares Community’s Bold Vision on Visit Aurora Podcast

    Fitzsimons Innovation Community President & CEO Kelly Brough was recently featured on Visit Aurora, Colorado’s The Gateway to the Rockies Podcast where she shared the bold vision behind the newly approved master plan and how the Fitzsimons campus is transforming into Aurora’s first true urban district. From cutting-edge research that’s reshaping patient care to green…
  • CU Anschutz
    • News

    National Trial: Ketamine Raises Heart Risk, No Survival Advantage Over Etomidate in Emergency Intubation

    CU Anschutz researchers help lead the largest U.S. randomized trial highlighting ketamine’s cardiovascular risks while guiding emergency and critical care practice.
  • Fitzsimons 25 years
    • Blog

    25 Things We’ve Learned in 25 Years

    As we close out this milestone year celebrating our 25th anniversary, we’ve been reflecting on the incredible journey from visionary concept to thriving hub of health and life sciences innovation. Throughout 2025, we’ve shared fun insights on social media about the lessons learned, the a-ha moments discovered, and the collective wisdom gathered from the brilliant minds who call our Community home. Now, we’re bringing all the fun together in one place—a celebration of what makes Fitzsimons Innovation Community truly special.
  • CU Anschutz
    • News

    New Study Finds Cystic Fibrosis Drug Allows Patients to Safely Scale Back Lung Therapies

    A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the triple-drug therapy elexacaftor/tezacaftor/ivacaftor (ETI) can safely reduce many of their daily lung treatments while maintaining good health for years.
  • CU Anschutz
    • News

    From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy for Resistant Ovarian Cancer

    A first-of-its-kind combination therapy could make treatment more effective by attacking hard-to-treat cancer from two angles.
    • News

    Fitzsimons Innovation Community Members Receive OEDIT Early-Stage Capital and Retention Grants

    The Global Business Development division of the Colorado Office of Economic Development and International Trade (OEDIT) announced that 17 Colorado companies and eight researchers have been awarded Proof of Concept and Early-Stage Capital and Retention grants through OEDIT’s Advanced Industries Accelerator Program. Congratulations to the Fitzsimons Innovation Community Early-Stage Capital and Retention Grant Recipients: Onconaut…
    • News

    UCHealth is First in Colorado to Offer Mammogram Technology that Better Detects Hidden Breast Cancer

    UCHealth said it’s the first in Colorado to offer a kind of mammogram that could be a game changer when it comes to detecting breast cancer. Dr. Elizabeth Vorhis, a breast radiologist said she uses an IV contrast during a mammogram. It’s the same kind of process if you go to the emergency room and…
    • News

    Fitzsimons Innovation Community Members Honored at CBSA 22nd Annual Awards Celebration

    Colorado BioScience Association (CBSA) announced the winners of its 22nd Annual Awards Celebration, recognizing the people and organizations advancing Colorado’s position as a leading hub for health innovation. The awards spotlight leaders whose work accelerates breakthrough discoveries and delivers impact for patients in Colorado and around the world. Dr. Katherine Goodman, Associate Professor at the…
    • News

    UCHealth Patient Pioneers Innovative Adaptive Brain Stimulation Device for Parkinson’s

    Earlier this year, Kate Goes became the first patient in North America to use FDA-approved adaptive deep brain stimulation (DBS) technology for Parkinson’s. UCHealth Ph.D. clinical neuropsychologist John Thompson helped make the pathbreaking innovation possible.
  • CU Anschutz
    • News

    CU Anschutz Researchers Make Drug Dosing Safer for Babies

    Earlier this year, Kate Goes became the first patient in North America to use FDA-approved adaptive deep brain stimulation (DBS) technology for Parkinson’s. UCHealth Ph.D. clinical neuropsychologist John Thompson helped make the pathbreaking innovation possible.